{"id":"https://genegraph.clinicalgenome.org/r/14cd6ad0-7aa4-494a-8f44-9697f33c181cv1.0","type":"EvidenceStrengthAssertion","dc:description":"*ALPL* was reported in relation to *ALPL*-related autosomal dominant hypophosphatasia as early as 1962 (Silverman et al., PMID: 13912932).  *ALPL*-related autosomal dominant hypophosphatasia is characterized by defective mineralization of bone and/or teeth, premature loss of teeth with intact roots, and reduced serum alkaline phosphatase (ALP) activity. Individuals can present with this form of hypophosphatasia in infancy, childhood, or adulthood. Per criteria outlined by the ClinGen Lumping and Splitting guidelines, we found no difference in molecular mechanism, inheritance pattern, and phenotypic variability. Therefore, the following autosomal dominant disease entities (Hypophosphatasia, adult, MIM:146300; Odontohypophosphatasia, MIM:146300) have been lumped into one disease entity, *ALPL*-related autosomal dominant hypophosphatasia. The split curation for *ALPL*-related autosomal recessive hypophosphatasia has been curated separately. \n\n20 missense, 1 frameshift, 1 nonsense, and one splicing variants that have been reported in 23 probands in 3 publications (PMIDs: 10690885, 19500388, 29236161) are included in this curation. More evidence is available in the literature, but the maximum score for genetic evidence (12 pts.) has been reached. The mechanism of disease is reported to be dominant negative. This gene-disease relationship is also supported by two animal models and expression studies (PMIDs: 25716980, 23715323). In summary, there is definitive evidence supporting the relationship between *ALPL* and *ALPL*-related autosomal dominant hypophosphatasia. This has been repeatedly demonstrated in both the research and clinical diagnostic settings, and has been upheld over time.This classification was approved by the ClinGen Skeletal Disorders GCEP on the meeting date May 19th, 2021 (SOP Version 8).\n","dc:isVersionOf":"https://genegraph.clinicalgenome.org/r/14cd6ad0-7aa4-494a-8f44-9697f33c181c","GCISnapshot":"https://genegraph.clinicalgenome.org/r/417cf2e3-52ab-4a2f-baf0-eb1baae622f8","calculatedEvidenceStrength":"Definitive","contributions":[{"id":"https://genegraph.clinicalgenome.org/r/417cf2e3-52ab-4a2f-baf0-eb1baae622f8_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2021-05-19T16:00:00.000Z","role":"Approver"},{"id":"https://genegraph.clinicalgenome.org/r/417cf2e3-52ab-4a2f-baf0-eb1baae622f8_publish_contrib","agent":"https://genegraph.clinicalgenome.org/agent/10065","date":"2025-06-02T20:28:10.499Z","role":"Publisher"}],"curationReasons":["NewCuration"],"evidence":[{"id":"https://genegraph.clinicalgenome.org/r/417cf2e3-52ab-4a2f-baf0-eb1baae622f8_overall_genetic_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a0ddbca-add6-4725-b20e-7c3fa05a077e","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/0a0ddbca-add6-4725-b20e-7c3fa05a077e_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/073ba0a4-8ace-4f7e-9fb3-4138a56cf10f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.323C>T (p.Pro108Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA123349"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/9aee5f68-43bc-4bdc-951d-d9f8413c900b","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9aee5f68-43bc-4bdc-951d-d9f8413c900b_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (30.5% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/9aee5f68-43bc-4bdc-951d-d9f8413c900b_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/a4afd1f7-ab13-409f-9b4c-c69541e0837b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.212G>A (p.Arg71His)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA19088467"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/07a5024b-ec87-4c79-899f-d898ce5bc691","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/07a5024b-ec87-4c79-899f-d898ce5bc691_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/1ebf1e6b-ddb0-4b34-b94f-444029206ee9","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1000G>C (p.Gly334Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338880940"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/604d92de-fe1b-45b2-b38b-5d84671407a9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/604d92de-fe1b-45b2-b38b-5d84671407a9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/6d2f221d-9e5c-48e4-acb4-22ee7377962d","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1133A>T (p.Asp378Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256928"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/5c0eded5-fcf9-40b3-82cd-e0910535958d","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5c0eded5-fcf9-40b3-82cd-e0910535958d_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (28.2% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5c0eded5-fcf9-40b3-82cd-e0910535958d_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/553e64d5-b9bf-432c-b60b-bb9fed30f841","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.299C>T (p.Thr100Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338877051"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e3d5cb17-5946-4897-a4b4-0d2554b7f17c","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e3d5cb17-5946-4897-a4b4-0d2554b7f17c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29236161","allele":{"id":"https://genegraph.clinicalgenome.org/r/3c2e254e-5d98-4209-8ac0-3dd8b22bcf3f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1171C>T (p.Arg391Cys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA666747"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/1a32df6a-0988-4028-a4a8-a088264706cb","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/1a32df6a-0988-4028-a4a8-a088264706cb_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (31% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/1a32df6a-0988-4028-a4a8-a088264706cb_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/5b8e9f60-256d-442c-a411-8de67a168ace","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1285G>A (p.Glu429Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338881853"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/e6c80d3c-ba9e-475e-bf4d-7537e173acdd","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/e6c80d3c-ba9e-475e-bf4d-7537e173acdd_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29236161","allele":{"id":"https://genegraph.clinicalgenome.org/r/f9873913-5494-475d-b267-bb61ee344696","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.187_205del (p.Gly63LeufsTer?)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA1139771350"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cb555f2f-bbc5-4806-bfa2-00ccae1935e4","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cb555f2f-bbc5-4806-bfa2-00ccae1935e4_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (19.7% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/cb555f2f-bbc5-4806-bfa2-00ccae1935e4_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/2fd557e7-4b0e-47e1-ab20-49136748b87e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1259G>C (p.Gly420Ala)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338881802"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/90f320d2-8de0-4f95-b14c-86386972fe95","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/90f320d2-8de0-4f95-b14c-86386972fe95_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (33% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/90f320d2-8de0-4f95-b14c-86386972fe95_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/6346bfda-e712-4f10-a36a-057dad45930f","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1015G>A (p.Gly339Arg)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338880993"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/b7e3fb13-de1a-4c07-a290-acacfe11649a","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/b7e3fb13-de1a-4c07-a290-acacfe11649a_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect ruled out - 7.2% of WT activity (Del Angel 2020)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/b7e3fb13-de1a-4c07-a290-acacfe11649a_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29236161","allele":{"id":"https://genegraph.clinicalgenome.org/r/fab9d125-5610-4e6d-b9c8-a867695403a0","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1328C>T (p.Ala443Val)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338881972"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/fddd0ef2-dc93-4124-8637-82c0786e04e6","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fddd0ef2-dc93-4124-8637-82c0786e04e6_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (36.7% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/fddd0ef2-dc93-4124-8637-82c0786e04e6_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/a63de7f6-2a9e-420f-bb72-ef36665d6644","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.550C>T (p.Arg184Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA666527"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/182282ed-f49b-4663-86a2-28307145c8e9","type":"EvidenceLine","calculatedScore":0.1,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/182282ed-f49b-4663-86a2-28307145c8e9_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/7f6776f7-6f3b-470f-8126-2834ebc7c54a","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1250A>G (p.Asn417Ser)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA199266"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.1},{"id":"https://genegraph.clinicalgenome.org/r/417cf2e3-52ab-4a2f-baf0-eb1baae622f8_seg_el","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/fff74705-0b64-4eff-835b-b363bc9eb2ce_proband_segregation","type":"FamilyCosegregation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10690885","rdfs:label":"Muller_family","estimatedLodScore":0.9,"family":{"id":"https://genegraph.clinicalgenome.org/r/fff74705-0b64-4eff-835b-b363bc9eb2ce","type":"Family","rdfs:label":"Muller_family","member":{"id":"https://genegraph.clinicalgenome.org/r/7b815273-c741-47bf-9408-934ea0d603a4","type":"Proband","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10690885","rdfs:label":"Muller proband","allele":{"id":"https://genegraph.clinicalgenome.org/r/6d2f221d-9e5c-48e4-acb4-22ee7377962d"},"firstTestingMethod":"PCR","phenotypes":["obo:HP_0003282","obo:HP_0003239","obo:HP_0006323"],"sex":"Male","variant":{"id":"https://genegraph.clinicalgenome.org/r/620a2af6-910a-49a4-b0e6-a2e556d1f396_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/10690885","allele":{"id":"https://genegraph.clinicalgenome.org/r/6d2f221d-9e5c-48e4-acb4-22ee7377962d"},"alleleOrigin":{"id":"cg:GermlineAlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}}},"meetsInclusionCriteria":true,"phenotypePositiveAllelePositive":4,"phenotypes":["obo:HP_0003239","obo:HP_0003282","obo:HP_0006323"],"proband":{"id":"https://genegraph.clinicalgenome.org/r/7b815273-c741-47bf-9408-934ea0d603a4"},"sequencingMethod":{"id":"cg:CandidateGeneSequencing"}}],"specifiedBy":"GeneValiditySegregationEvidenceCriteria","strengthScore":0},{"id":"https://genegraph.clinicalgenome.org/r/aa3083b4-4c6a-429b-8d4a-53f119af529c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/aa3083b4-4c6a-429b-8d4a-53f119af529c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (40% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/aa3083b4-4c6a-429b-8d4a-53f119af529c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/3c996c09-f4ab-404c-bf2e-588fec277a07","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1001G>A (p.Gly334Asp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256929"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/620a2af6-910a-49a4-b0e6-a2e556d1f396","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/620a2af6-910a-49a4-b0e6-a2e556d1f396_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Mutant showed decreased activities in COS cells","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/620a2af6-910a-49a4-b0e6-a2e556d1f396_variant_evidence_item"}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/dfdf5202-7281-4690-8bbc-63f280a76da5","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/dfdf5202-7281-4690-8bbc-63f280a76da5_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (40.2% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/dfdf5202-7281-4690-8bbc-63f280a76da5_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/d617b3e2-02fb-4d59-a360-5fc7e8921a42","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.215T>C (p.Ile72Thr)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA274142"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/a1427d99-4bcd-4513-a019-87b296219376","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/a1427d99-4bcd-4513-a019-87b296219376_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29236161","allele":{"id":"https://genegraph.clinicalgenome.org/r/2c4a63a6-6034-4111-8d4f-8765fb44b94b","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.997+2T>A","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338880452"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/cf5c09f9-9852-433e-8024-5d8c311a18f2","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cf5c09f9-9852-433e-8024-5d8c311a18f2_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"21.4% of WT activity (Del Angel 2020)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/cf5c09f9-9852-433e-8024-5d8c311a18f2_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29236161","allele":{"id":"https://genegraph.clinicalgenome.org/r/4b3bb769-61e5-4d9a-9028-522939781f51","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.571G>A (p.Glu191Lys)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA256927"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/33bae8c5-d5c5-416b-88dd-87b290bde94c","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/33bae8c5-d5c5-416b-88dd-87b290bde94c_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (41.1% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/33bae8c5-d5c5-416b-88dd-87b290bde94c_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/c393f2cc-dea6-4aa6-83b6-c5a4bb9fe817","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1375G>T (p.Val459Leu)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338882067"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/5eff4b32-f904-427f-86a8-a0ba28c200b3","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5eff4b32-f904-427f-86a8-a0ba28c200b3_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"The dominant negative effect was measured by co-transfecting wild type (WT) and mutant cDNAs in COS cells and assaying the AP activity. The mutant with WT has activity that is 14.5% compared to that of WT activity.","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/5eff4b32-f904-427f-86a8-a0ba28c200b3_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/4c0b0dff-5385-403b-9d4e-7a406739744e","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1366G>T (p.Gly456Trp)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338882045"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8cf089c7-f9e7-45a9-abf0-3996b4183e43","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8cf089c7-f9e7-45a9-abf0-3996b4183e43_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (23.5% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/8cf089c7-f9e7-45a9-abf0-3996b4183e43_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/4d704832-a1a0-49b4-99f0-9707f1b72f79","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1240C>A (p.Leu414Met)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338881760"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/d6a15f3e-59b7-408d-a684-ddb8f55e6649","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d6a15f3e-59b7-408d-a684-ddb8f55e6649_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect shown in COS cells (35% compared to WT)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/d6a15f3e-59b7-408d-a684-ddb8f55e6649_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/19500388","allele":{"id":"https://genegraph.clinicalgenome.org/r/6346bfda-e712-4f10-a36a-057dad45930f"},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5},{"id":"https://genegraph.clinicalgenome.org/r/8f7044f1-574e-47a6-84d0-bf45b5138690","type":"EvidenceLine","calculatedScore":1.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/8f7044f1-574e-47a6-84d0-bf45b5138690_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29236161","allele":{"id":"https://genegraph.clinicalgenome.org/r/b4f96f7c-3f63-4ade-b934-3169cfa21431","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.809G>A (p.Trp270Ter)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA274277"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNullVariantCriteria","strengthScore":1.5},{"id":"https://genegraph.clinicalgenome.org/r/35bf7f2a-2ba7-4f8d-8ff7-11732eddb4fa","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/35bf7f2a-2ba7-4f8d-8ff7-11732eddb4fa_function_evidence_item","type":"VariantFunctionalImpactEvidence","dc:description":"Dominant negative effect ruled out - 37.1% of WT activity (Fauvert 2009)","functionalDataSupport":"Yes"},{"id":"https://genegraph.clinicalgenome.org/r/35bf7f2a-2ba7-4f8d-8ff7-11732eddb4fa_variant_evidence_item","type":"VariantObservation","dc:source":"https://pubmed.ncbi.nlm.nih.gov/29236161","allele":{"id":"https://genegraph.clinicalgenome.org/r/efbae290-60fb-4da5-beb9-7b338fcc7f83","type":"https://terms.ga4gh.org/VariationDescriptor","http://www.w3.org/2004/02/skos/core#prefLabel":"NM_000478.6(ALPL):c.1468A>T (p.Ile490Phe)","https://terms.ga4gh.org/CanonicalReference":{"id":"http://reg.genome.network/allele/CA338882313"}},"alleleOrigin":{"id":"cg:AlleleOrigin"},"zygosity":{"id":"cg:Heterozygous"}}],"specifiedBy":"GeneValidityNonNullVariantCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallGeneticEvidenceCriteria","strengthScore":12},{"id":"https://genegraph.clinicalgenome.org/r/417cf2e3-52ab-4a2f-baf0-eb1baae622f8_experimental_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/417cf2e3-52ab-4a2f-baf0-eb1baae622f8_model_rescue_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/5e0252ad-c72d-4960-95d9-d4f38e257e8a","type":"EvidenceLine","dc:description":"Downgraded because wide phenotypic spectrum of sheep","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/cc68c212-9299-4bcb-97b8-029e59107b66","type":"Finding","dc:description":"Both humans and sheep experience dental abnormalities","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25716980","rdfs:label":"Foster sheep","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":1},{"id":"https://genegraph.clinicalgenome.org/r/7f1d9979-2441-4927-9f8b-4ca0739b99a4","type":"EvidenceLine","calculatedScore":2,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/d5e31db5-2eb2-4d9a-adde-03633d6e13ab","type":"Finding","dc:description":"Both humans and mice experience dental phenotypes and were correlated with plasma ALP activity.","dc:source":"https://pubmed.ncbi.nlm.nih.gov/25716980","rdfs:label":"Foster mouse","demonstrates":{"id":"cg:ProteinAlterationDisruptsOrganismFunction"}}],"specifiedBy":"GeneValidityNonHumanModelOrganismCriteria","strengthScore":2}],"specifiedBy":"GeneValidityOverallModelAndRescueEvidenceCriteria","strengthScore":3},{"id":"https://genegraph.clinicalgenome.org/r/417cf2e3-52ab-4a2f-baf0-eb1baae622f8_functional_evidence_line","type":"EvidenceLine","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/9e7771f8-fede-4a80-84cf-e22e48a41779","type":"EvidenceLine","calculatedScore":0.5,"direction":"Supports","evidence":[{"id":"https://genegraph.clinicalgenome.org/r/ac2dbd79-d04f-43cf-8671-de919ddbc8d2","type":"Finding","dc:description":"mRNA data shows expression in whole blood, marrow, and bone","dc:source":"https://pubmed.ncbi.nlm.nih.gov/23715323","rdfs:label":"GTEx Expression","demonstrates":{"id":"cg:GeneExpressionA"}}],"specifiedBy":"GeneValidityGeneExpressionCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallFunctionalEvidenceCriteria","strengthScore":0.5}],"specifiedBy":"GeneValidityOverallExperimentalEvidenceCriteria","strengthScore":3.5}],"evidenceStrength":"Definitive","sequence":10521,"specifiedBy":"GeneValidityCriteria8","strengthScore":15.5,"subject":{"id":"https://genegraph.clinicalgenome.org/r/kDE8PJUc3Y4","type":"GeneValidityProposition","disease":"obo:MONDO_0100608","gene":"hgnc:438","modeOfInheritance":"obo:HP_0000006"},"version":"1.0","websiteLegacyID":"https://genegraph.clinicalgenome.org/r/assertion_417cf2e3-52ab-4a2f-baf0-eb1baae622f8-","@context":{"@vocab":"https://genegraph.clinicalgenome.org/terms/","id":"@id","type":"@type","cg":"https://genegraph.clinicalgenome.org/terms/","dc":"http://purl.org/dc/terms/","obo":"http://purl.obolibrary.org/obo/","hgnc":"https://identifiers.org/hgnc:","rdfs":"http://www.w3.org/2000/01/rdf-schema#","cggv":"https://genegraph.clinicalgenome.org/r/gci/","evidenceStrength":{"@type":"@vocab"},"calculatedEvidenceStrength":{"@type":"@vocab"},"computedEvidenceStrength":{"@type":"@vocab"},"specifiedBy":{"@type":"@vocab"},"evidence":{"@container":"@set"},"disease":{"@type":"@vocab"},"gene":{"@type":"@vocab"},"phenotypes":{"@type":"@id"},"agent":{"@type":"@id"},"role":{"@type":"@vocab"},"modeOfInheritance":{"@type":"@vocab"},"sex":{"@type":"@vocab"},"direction":{"@type":"@vocab"},"ageType":{"@type":"@vocab"},"ageUnit":{"@type":"@vocab"},"dc:source":{"@type":"@id"},"curationReasons":{"@type":"@vocab","@container":"@set"},"GCISnapshot":{"@type":"@id"},"dc:isVersionOf":{"@type":"@id"},"websiteLegacyID":{"@type":"@id"}}}